XRDC is part of the Informa Tech Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

XRDC 2018 Session Scheduler

View, browse and sort the ever-growing list of XRDC 2018 sessions by pass type, track, and format. With XRDC 2018’s Session Scheduler, you can build your schedule in advance and access it during the show via export or with the XRDC Mobile App. Sessions do fill up, so please arrive early to sessions that you would like to attend. Adding a session to your schedule does not guarantee you a seat.

In order to best utilize Session Scheduler, please use the same login credentials you’ve set up on this page as your login credentials on the XRDC Mobile App. Your login credentials are the same your as your registration login. You can download the app on iTunes or Google Play.

Games as Medicine: FDA Clearance Tradeoffs

Noah Falstein (President, The Inspiracy)

Location: California East, Second Floor, Tower Building

Date: Monday, October 29

Time: 2:45pm - 3:15pm

Pass Type: XRDC Pass - Get your pass now!

Track: Healthcare

Format: Session

Vault Recording: Video

Audience Level: All

In early 2018, for the first time, software is expected to be cleared by the FDA to be prescribed by doctors to treat children with ADHD, opening the $300 billion annual US pharmaceutical market to game developers. Two other game-related treatments have already received FDA device clearance, a different type of clearance, and AR & VR creators are increasingly interested in this concept.

In this talk, you can learn specifics of three companies that have applied to get their (non-XR) games reviewed in FDA trials, hear the business, technical, creative, and scientific challenges involved in creating and testing this sort of game, and other opportunities for games as medicine that are opening in the near future.

This talk will also focus on why many XR-based Games for Health have not yet gotten FDA clearance, and possible solutions for this going forward. FDA review of software as treatment opens new markets for developers and provides positive news about the benefits of games, but also exposes them to more scrutiny. Come hear how to effectively deal with these opportunities and challenges.


Attendees will hear about the specific challenges of FDA clearance and specific challenges for XR, as well as more general issues for studios, individuals, and patients in creating games for health. Come learn how to build your company, your career, or just learn about games rigorously proven to help people.

Intended Audience

The talk will cover business, technical, creative and scientific challenges and should be of interest to all attendees regardless of skill set. Studio heads, programmers, designers, producers, and all content creators will find relevant information.